Publication date: Oct 01, 2024
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | intervention |
disease | MESH | COVID-19 |
disease | IDO | role |
disease | IDO | facility |
disease | IDO | site |
disease | MESH | health status |
pathway | REACTOME | Reproduction |
disease | IDO | country |
drug | DRUGBANK | Trestolone |
drug | DRUGBANK | Coenzyme M |
disease | MESH | acquired immunodeficiency syndrome |
disease | MESH | tuberculosis |
pathway | KEGG | Tuberculosis |
disease | MESH | silicosis |
drug | DRUGBANK | Serine |
disease | MESH | emergency |
drug | DRUGBANK | Water |
disease | MESH | death |
disease | MESH | pneumoconiosis |
disease | MESH | communicable diseases |
disease | MESH | uncertainty |
drug | DRUGBANK | Indoleacetic acid |
disease | IDO | process |
disease | IDO | quality |
drug | DRUGBANK | Etoperidone |
disease | MESH | social problems |
disease | MESH | lifestyle |
drug | DRUGBANK | Tretamine |
disease | IDO | immunodeficiency |
drug | DRUGBANK | Platinum |
drug | DRUGBANK | Aspartame |
disease | IDO | host |
disease | IDO | history |
drug | DRUGBANK | Sodium lauryl sulfate |
Original Article
(Visited 5 times, 1 visits today)